Nycomed requests further covenant relief
Swiss private equity-backed drug company Nycomed has asked its lenders for covenant relief as it looks at ways of managing its debts.
The company, owned by Nordic Capital, DLJ Merchant Banking, Coller International Partners and Avista, has net debt of around $3.7bn.
Nycomed reportedly asked lenders to reset its covenants in exchange for a 50 basis point fee and a 100 basis point increase in interest rates. It negotiated 25% covenant relief in March.
The firm, acquired by private equity investors in 2007, has been rumoured to be seeking an IPO as part of an exit strategy.
Latest News
Stonehage Fleming raises USD 130m for largest fund to date, eyes 2024 programme
Sponsor acquired the public software group in July 2017 via the same-year vintage Partners Group Global Value 2017
Stonehage Fleming raises USD 130m for largest fund to date, eyes 2024 programme
Czech Republic-headquartered family office is targeting DACH and CEE region deals
Stonehage Fleming raises USD 130m for largest fund to date, eyes 2024 programme
Ex-Rocket Internet leader Bettina Curtze joins Swiss VC firm as partner and CFO
Stonehage Fleming raises USD 130m for largest fund to date, eyes 2024 programme
Estonia-registered VC could bolster LP base with fresh capital from funds-of-funds or pension funds








